<DOC>
	<DOCNO>NCT01830140</DOCNO>
	<brief_summary>This safety study evaluate bimatoprost 0.01 % 0.03 % patient glaucoma ocular hypertension ( OHT ) .</brief_summary>
	<brief_title>A Safety Study Bimatoprost Patients With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Diagnosis glaucoma ocular hypertension Active ocular disease glaucoma ocular hypertension Require chronic use ocular medication study medication study ( intermittent use artificial tear solution permit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>